Products Informtion

---

Name:

MABTHERA

Registration Date:

2017-12-20 00:00:00

Generic Name:

Generic_Name

Strength:

500MG/50ML

Classification:

HIGH RISK

Active Ingredient:

RITUXIMAB

Dosage Form Indication:

INJECTABLE SOLUTION_INDICATED FOR TREATMENT OF BLOOD CANCERS AND INFLAMMATORY CONDITIONS

Representative Company:

F. HOFFMAN LA-ROCHE GHANA LTD

Manufacturer:

F. HOFFMANN-LA ROCHE LTD.(Switzerland)

Applicant:

F. HOFFMAN LA-ROCHE GHANA LTD

Expiry_date:

2021-01-01 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

RECORMON 4000 I.U

Registration Date:

2017-12-20 00:00:00

Generic Name:

ERYTHROPOEITIN

Strength:

4000I.U/0.3ML

Classification:

HIGH RISK

Active Ingredient:

EPOITIN BETA

Dosage Form Indication:

INJECTABLE SOLUTION_INDICATED FOR SYMPTOMATIC ANAEMIA ASSOCIATED WITH CRF IN ADULTS AND PAEDIATRIC PATIENTS

Representative Company:

F. HOFFMAN LA-ROCHE GHANA LTD

Manufacturer:

ROCHE DIAGNOSTICS GmbH

Applicant:

F. HOFFMANN-LA ROCHE LTD.(Switzerland)

Expiry_date:

2021-01-01 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

RECORMON 2000 I.U

Registration Date:

2017-12-20 00:00:00

Generic Name:

ERYTHROPOEITIN

Strength:

2000I.U/0.3ML

Classification:

HIGH RISK

Active Ingredient:

EPOITIN BETA

Dosage Form Indication:

INJECTABLE SOLUTION_INDICATED FOR SYMPTOMATIC ANAEMIA ASSOCIATED WITH CRF IN ADULTS AND PAEDIATRIC PATIENTS

Representative Company:

F. HOFFMAN LA-ROCHE GHANA LTD

Manufacturer:

ROCHE DIAGNOSTICS GmbH

Applicant:

F. HOFFMANN-LA ROCHE LTD.(Switzerland)

Expiry_date:

2021-01-01 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

PEGASYS PREFILLED

Registration Date:

2019-05-28 00:00:00

Generic Name:

HEPATITIS VACCINE

Strength:

180UG/ 0.5 ML

Classification:

HIGH RISK

Active Ingredient:

PEGINTERFERON ALFA-2A

Dosage Form Indication:

INJECTABLE SOLUTION_FOR TREATMENT OF HEPATITIS B AND C

Representative Company:

F. HOFFMAN LA-ROCHE GHANA LTD ROCHE LIMITED

Manufacturer:

F. HOFFMANN-LA ROCHE LTD.(Switzerland)

Applicant:

F. HOFFMANN-LA ROCHE LTD.(Switzerland)

Expiry_date:

2022-01-06 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

NOVOMIX 30 FLEXPEN

Registration Date:

2019-05-30 00:00:00

Generic Name:

INSULIN

Strength:

100 I.U/ML

Classification:

HIGH RISK

Active Ingredient:

INSULIN ASPART

Dosage Form Indication:

INJECTABLE SUSPENSION_FOR DIABETES TREATMENT

Representative Company:

GOKALS-LABOREX LTD

Manufacturer:

NOVO NORDISK A/S (DENMARK)

Applicant:

NOVO NORDISK PHARMA GULF FZ-LLC

Expiry_date:

2022-01-07 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

LEVEMIR FLEXPEN

Registration Date:

2019-05-30 00:00:00

Generic Name:

INSULIN

Strength:

100 I.U/ML

Classification:

HIGH RISK

Active Ingredient:

INSULIN DETEMIR

Dosage Form Indication:

INJECTABLE SOLUTION_FOR DIABETES TREATMENT

Representative Company:

GOKALS-LABOREX LTD

Manufacturer:

NOVO NORDISK A/S (DENMARK)

Applicant:

NOVO NORDISK PHARMA GULF FZ-LLC

Expiry_date:

2022-01-07 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

NOVORAPID FLEXPEN

Registration Date:

2019-05-30 00:00:00

Generic Name:

INSULIN

Strength:

100 I.U/ML

Classification:

HIGH RISK

Active Ingredient:

INSULIN ASPART

Dosage Form Indication:

INJECTABLE SOLUTION_FOR DIABETES TREATMENT

Representative Company:

GOKALS-LABOREX LTD

Manufacturer:

NOVO NORDISK A/S (DENMARK)

Applicant:

NOVO NORDISK PHARMA GULF FZ-LLC

Expiry_date:

2022-01-07 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

LUCENTIS

Registration Date:

2018-08-24 00:00:00

Generic Name:

RANIBIZUMAB

Strength:

10 MG/ML

Classification:

HIGH RISK

Active Ingredient:

RANIBIZUMAB

Dosage Form Indication:

INJECTABLE SOLUTION_INDICATED FOR ANTI-NEOVASCULARIZATION

Representative Company:

OSON'S CHEMIST LTD ERNEST CHEMISTS LIMITED

Manufacturer:

NOVARTIS PHARMA STEIN AG

Applicant:

NOVARTIS PHARMA AG

Expiry_date:

2021-01-09 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

INSUMAN BASAL VIAL

Registration Date:

2018-04-17 00:00:00

Generic Name:

INSULIN

Strength:

100 UNITS/ML

Classification:

HIGH RISK

Active Ingredient:

HUMAN INSULIN

Dosage Form Indication:

INJECTABLE SUSPENSION_ANTI-DIABETIC AGENT

Representative Company:

GOKALS-LABOREX LTD

Manufacturer:

SANOFI- AVENTIS DEUTSCHLAND GmbH

Applicant:

SANOFI- AVENTIS DEUTSCHLAND GmbH

Expiry_date:

2021-01-05 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

APIDRA

Registration Date:

2020-09-03 00:00:00

Generic Name:

INSULIN

Strength:

100I.U/ML

Classification:

HIGH RISK

Active Ingredient:

INSULIN GLULISINE

Dosage Form Indication:

INJECTABLE SOLUTION_TREATMENT OF DIABETES

Representative Company:

GOKALS-LABOREX LTD

Manufacturer:

SANOFI- AVENTIS DEUTSCHLAND GmbH

Applicant:

SANOFI AVENTIS NIGERIA LIMITED

Expiry_date:

2023-01-04 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

STAMARIL

Registration Date:

2019-08-14 00:00:00

Generic Name:

YELLOW FEVER VACCINE

Strength:

1000 I.U ( 17D-204 STRAIN)

Classification:

HIGH RISK

Active Ingredient:

YELLOW FEVER LIVE VIRUS, ATENUATED

Dosage Form Indication:

POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION_INDICATED AGAINST YELLOW FEVER INFECTION

Representative Company:

GOKALS-LABOREX LTD

Manufacturer:

SANOFI PASTEUR SA

Applicant:

SANOFI AVENTIS NIGERIA LIMITED

Expiry_date:

2022-01-09 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

PRIORIX VACCINE

Registration Date:

2020-05-29 00:00:00

Generic Name:

MMR VACCINE

Strength:

0.5 ML/DOSE

Classification:

HIGH RISK

Active Ingredient:

LIVE ATTENUATED MEASLES VIRUS1 (SCHWARZ STRAIN) NOT LESS THAN 103.0 CCID503 LIVE ATTENUATED MUMPS VIRUS1 (RIT 4385 STRAIN, DERIVED FROM JERYL LYNN STRAIN) NOT LESS THAN 103.7 CCID503 LIVE ATTENUATED RUBELLA VIRUS2 (WISTAR RA 27/3 STRAIN) NOT LESS THAN 103.0 CCID503 ; (1) PRODUCED IN CHICK EMBRYO CELLS (2) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS (3) CELL CULTURE INFECTIVE DOSE 50%

Dosage Form Indication:

POWDER AND SOLVENT FOR RECONSTITUTION FOR INJECTION_INDICATED FOR ACTIVE IMMUNIZATION AGAINST MEASLES, MUMPS AND RUBELLA

Representative Company:

WORLDWIDE HEALTHCARE LIMITED

Manufacturer:

GLAXOSMITHKLINE BIOLOGICALS S. A.

Applicant:

GLAXOSMITHKLINE BIOLOGICALS S. A.

Expiry_date:

2023-01-07 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

VERORAB VACCINE

Registration Date:

2019-08-14 00:00:00

Generic Name:

RABIES VACCINE

Strength:

0.5ML/DOSE

Classification:

HIGH RISK

Active Ingredient:

WISTAR RABIES PM/WI38 1503-3M STRAIN (INACTIVATED)

Dosage Form Indication:

POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION_INDICATED FOR THE PREVENTION OF RABIES IN CHILDREN AND ADULTS

Representative Company:

GOKALS-LABOREX LTD

Manufacturer:

SANOFI PASTEUR SA

Applicant:

SANOFI AVENTIS NIGERIA LIMITED

Expiry_date:

2022-01-09 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

ROTARIX VACCINE

Registration Date:

2020-05-29 00:00:00

Generic Name:

ROTAVIRUS VACCINE

Strength:

1.5ML/ DOSE

Classification:

HIGH RISK

Active Ingredient:

HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE, ATTENUATED)

Dosage Form Indication:

ORAL SUSPENSION_INDICATED FOR THE PREVENTION OF ROTAVIRUS GASTROENTERITIS CAUSED BY G1 AND NON G1 TYPES

Representative Company:

WORLDWIDE HEALTHCARE LIMITED

Manufacturer:

GLAXOSMITHKLINE BIOLOGICALS S. A.

Applicant:

GLAXOSMITHKLINE BIOLOGICALS S. A.

Expiry_date:

2023-01-06 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

ENGERIX B ADULT

Registration Date:

2018-01-25 00:00:00

Generic Name:

HEPATITIS B VACCINE

Strength:

0.5ML/DOSE

Classification:

HIGH RISK

Active Ingredient:

HEPATITIS B SURFACE ANTIGEN E

Dosage Form Indication:

INJECTABLE SUSPENSION_INDICATED FOR ACTIVE IMMUNIZATION AGANST HBV INFECTION IN ADULT

Representative Company:

WORLDWIDE HEALTHCARE LIMITED

Manufacturer:

GLAXOSMITHKLINE BIOLOGICALS S. A.

Applicant:

GLAXOSMITHKLINE BIOLOGICALS S. A.

Expiry_date:

2021-01-02 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

TYPHIM VI

Registration Date:

2019-08-14 00:00:00

Generic Name:

TYPHOID VI

Strength:

5 ML/DOSE

Classification:

HIGH RISK

Active Ingredient:

PURIFIED VI CAPSULAR POLYSACCHARIDE OF SALMONELLA TYPHI (TY 2 STRAIN)

Dosage Form Indication:

INJECTABLE SOLUTION_INDICATED AGAINST THE PREVENTION OF TYPHOID FEVER IN ADULTS AND CHILDREN OVER 2 YEARS OF AGE

Representative Company:

GOKALS-LABOREX LTD

Manufacturer:

SANOFI PASTEUR SA

Applicant:

SANOFI AVENTIS NIGERIA LIMITED

Expiry_date:

2022-01-09 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

HAVRIX 1440 ADULT

Registration Date:

2018-11-04 00:00:00

Generic Name:

HEPATITIS A VACCINE

Strength:

1 ML/DOSE

Classification:

HIGH RISK

Active Ingredient:

HEPATITIS A VIRUS (HM175 STRAIN), INACTIVATED

Dosage Form Indication:

INJECTABLE SUSPENSION_INDICATED FOR ACTIVE IMMUNIZATION AGAINST HEPATITIS A INFECTION IN SUBJECTS AT RISK TO THE DISEASES

Representative Company:

WORLDWIDE HEALTHCARE LIMITED

Manufacturer:

GLAXOSMITHKLINE BIOLOGICALS S. A.

Applicant:

GLAXOSMITHKLINE BIOLOGICALS S. A.

Expiry_date:

2021-01-05 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

ENGERIX B PAEDIATRIC

Registration Date:

2018-01-25 00:00:00

Generic Name:

HEPATITIS B VACCINE

Strength:

0.5ML/DOSE

Classification:

HIGH RISK

Active Ingredient:

HEPATITIS B SURFACE ANTIGEN

Dosage Form Indication:

INJECTABLE SUSPENSION_INDICATED FOR ACTIVE IMMUNIZATION AGANST HBV INFECTION

Representative Company:

WORLDWIDE HEALTHCARE LIMITED

Manufacturer:

GLAXOSMITHKLINE BIOLOGICALS S. A.

Applicant:

GLAXOSMITHKLINE BIOLOGICALS S. A.

Expiry_date:

2021-01-02 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

MENACTRA

Registration Date:

2019-08-14 00:00:00

Generic Name:

MENINGITIS VACCINE

Strength:

0.5 ML/DOSE

Classification:

HIGH RISK

Active Ingredient:

MENINGOCOCCAL CONJUGATE VACCINE

Dosage Form Indication:

INJECTABLE SOLUTION_INDICATED FOR ACTIVE IMMUNIZATION TO PREVENT INVASIVE MENINGOCOCCAL DISEASE CAUSED BY NEISSERIA MENINGITIDIS SEROGROUPS A, C, Y AND W-135. MENACTRA IS APPROVED FOR USE IN INDIVIDUALS 9 MONTHS THROUGH 55 YEARS OF AGE. MENACTRA DOES NOT PREVENT N MENINGITIS

Representative Company:

GOKALS-LABOREX LTD

Manufacturer:

SANOFI PASTEUR SA

Applicant:

SANOFI AVENTIS NIGERIA LIMITED

Expiry_date:

2022-01-09 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

APIDRA SOLOSTAR

Registration Date:

2020-09-10 00:00:00

Generic Name:

INSULIN

Strength:

100I.U/ML

Classification:

HIGH RISK

Active Ingredient:

INSULIN GLULISINE

Dosage Form Indication:

INJECTABLE SOLUTION_INDICATED FOR TREATMENT OF DIABETES

Representative Company:

GOKALS-LABOREX LTD

Manufacturer:

SANOFI- AVENTIS DEUTSCHLAND GmbH

Applicant:

SANOFI AVENTIS NIGERIA LIMITED

Expiry_date:

2023-01-11 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

SHANCHOL VACCINE

Registration Date:

2019-08-14 00:00:00

Generic Name:

CHOLERA VACCINE

Strength:

1.5ML/ DOSE

Classification:

HIGH RISK

Active Ingredient:

KILLED BIVALENT V.CHOLERAE (O1 AND O139) STRAINS

Dosage Form Indication:

ORAL SUSPENSION_INDICATED FOR ACTIVE IMMUNIZATION AGAINST CHOLERIA DISEASE CAUSED BY VIBRIO CHOLERAE. THE VACCINE CAN BE ADMINISTERED TO ANYONE ABOVE THE AGE OF 1 YEAR

Representative Company:

GOKALS-LABOREX LTD

Manufacturer:

SHANTHA BIOTECHNICS LIMITED

Applicant:

SANOFI AVENTIS NIGERIA LIMITED

Expiry_date:

2022-01-09 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

VARILRIX

Registration Date:

2018-12-13 00:00:00

Generic Name:

VARICELLA VACCINE

Strength:

0.5ML/DOSE

Classification:

HIGH RISK

Active Ingredient:

VARICELLA ZOSTER ( IS A LYOPHILISED PREPARATION OF THE LIVE ATTENUATED OKA STRAIN OF VARICELLA-ZOSTER VIRUS,

Dosage Form Indication:

INJECTABLE POWDER (LYOPHILIZED) AND SOLVENT FOR RECONSTITUTION FOR INJECTION_INDICATED FOR ACTIVE IMMUNISATION AGAINST VARICELLA OF HEALTHY CHILDREN AND ADULTS FROM 9 MONTHS OF AGE

Representative Company:

GLAXOSMITHKLINE EXPORT GHANA LIMITED

Manufacturer:

GLAXOSMITHKLINE BIOLOGICALS S. A.

Applicant:

GLAXOSMITHKLINE BIOLOGICALS S. A.

Expiry_date:

2021-01-01 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

INSULATARD FLEXPEN

Registration Date:

2020-04-16 00:00:00

Generic Name:

INSULIN

Strength:

100 I. U./ML

Classification:

HIGH RISK

Active Ingredient:

OBTAINED BY PROPAGATION OF THE VIRUS IN MRC5 HUMAN DIPLOID CELL CULTURE).

Dosage Form Indication:

INJECTABLE SUSPENSION_FOR DIABETES TREATMENT

Representative Company:

GOKALS-LABOREX LTD

Manufacturer:

NOVO NORDISK A/S (DENMARK)

Applicant:

NOVO NORDISK PHARMA GULF FZ-LLC

Expiry_date:

2023-01-04 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

ACTRAPID FLEXPEN

Registration Date:

2020-04-16 00:00:00

Generic Name:

HUMAN INSULIN

Strength:

100 I. U./ML

Classification:

HIGH RISK

Active Ingredient:

INSULIN HUMAN (rDNA)

Dosage Form Indication:

INJECTABLE SOLUTION_FOR DIABETES TREATMENT

Representative Company:

GOKALS-LABOREX LTD

Manufacturer:

NOVO NORDISK A/S (DENMARK)

Applicant:

NOVO NORDISK PHARMA GULF FZ-LLC

Expiry_date:

2023-01-04 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

MIXTARD 30 FLEXPEN

Registration Date:

2020-04-16 00:00:00

Generic Name:

INSULIN

Strength:

100 I. U./ML

Classification:

HIGH RISK

Active Ingredient:

INSULIN HUMAN (rDNA)

Dosage Form Indication:

INJECTABLE SUSPENSION_FOR DIABETES TREATMENT

Representative Company:

GOKALS-LABOREX LTD

Manufacturer:

NOVO NORDISK A/S (DENMARK)

Applicant:

NOVO NORDISK PHARMA GULF FZ-LLC

Expiry_date:

2023-01-04 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

MIXTARD 30 VIAL

Registration Date:

2020-04-16 00:00:00

Generic Name:

INSULIN

Strength:

100 I. U./ML

Classification:

HIGH RISK

Active Ingredient:

INSULIN HUMAN (rDNA)

Dosage Form Indication:

INJECTABLE SUSPENSION_FOR DIABETES TREATMENT

Representative Company:

GOKALS-LABOREX LTD

Manufacturer:

NOVO NORDISK A/S (DENMARK)

Applicant:

NOVO NORDISK PHARMA GULF FZ-LLC

Expiry_date:

2023-01-04 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

HERCEPTIN SC

Registration Date:

2018-06-19 00:00:00

Generic Name:

TRASTUZUMAB

Strength:

600 MG

Classification:

HIGH RISK

Active Ingredient:

TRASTUZUMAB

Dosage Form Indication:

INJECTABLE SOLUTION_FOR TREATMENT OF BREAST CANCER

Representative Company:

F. HOFFMAN LA-ROCHE GHANA LTD

Manufacturer:

F. HOFFMANN-LA ROCHE LTD.(Switzerland)

Applicant:

F. HOFFMAN LA-ROCHE GHANA LTD

Expiry_date:

2021-01-07 00:00:00

Registration / Re-registration:

REG

Products Informtion

---

Name:

AVASTIN

Registration Date:

2020-02-28 00:00:00

Generic Name:

BEVACIZUMAB

Strength:

400 MG /16ML 100MG/4ML

Classification:

HIGH RISK

Active Ingredient:

BEVACIZUMAB

Dosage Form Indication:

INJECTABLE SOLUTION_FOR TREATEMENT OF METASTATIC COLORECTAL CANCER

Representative Company:

ROCHE LIMITED

Manufacturer:

ROCHE REGISTRATION LIMITED

Applicant:

ROCHE REGISTRATION LIMITED

Expiry_date:

2023-01-03 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

ACTRAPID VIAL

Registration Date:

2020-04-16 00:00:00

Generic Name:

HUMAN INSULIN

Strength:

100 I. U./ML

Classification:

HIGH RISK

Active Ingredient:

INSULIN HUMAN (rDNA)

Dosage Form Indication:

INJECTABLE SOLUTION_FOR DIABETES TREATMENT

Representative Company:

GOKALS-LABOREX LTD

Manufacturer:

NOVO NORDISK A/S (DENMARK)

Applicant:

NOVO NORDISK PHARMA GULF FZ-LLC

Expiry_date:

2023-01-04 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

INSULATARD VIAL

Registration Date:

2020-04-16 00:00:00

Generic Name:

INSULIN

Strength:

100 I. U./ML

Classification:

HIGH RISK

Active Ingredient:

INSULIN HUMAN (rDNA)

Dosage Form Indication:

INJECTABLE SUSPENSION_FOR DIABETES TREATMENT

Representative Company:

GOKALS-LABOREX LTD

Manufacturer:

NOVO NORDISK A/S (DENMARK)

Applicant:

NOVO NORDISK PHARMA GULF FZ-LLC

Expiry_date:

2023-01-04 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

LANTUS SOLUTION FOR INJECTION IN A VIAL

Registration Date:

2018-03-26 00:00:00

Generic Name:

INSULIN

Strength:

100 I.U/ML

Classification:

HIGH RISK

Active Ingredient:

INSULIN GLARGINE

Dosage Form Indication:

INJECTABLE SOLUTION_FOR DIABETES TREATMENT

Representative Company:

GOKALS-LABOREX LTD

Manufacturer:

SANOFI- AVENTIS DEUTSCHLAND GmbH

Applicant:

SANOFI AVENTIS NIGERIA LIMITED

Expiry_date:

2021-01-04 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

CETROTIDE

Registration Date:

2020-01-11 00:00:00

Generic Name:

CETRORELIX

Strength:

0.25MG/DOSE

Classification:

HIGH RISK

Active Ingredient:

CETRORELIX ACETATE

Dosage Form Indication:

POWER AND SOLVENT FOR INJECTION_INDICATED FORPREVENTION OF PREMATURE OVULATION IN PATIENTS UNDERGOING A CONTROLLED OVARIAN STIMULATION, FOLLOWED BY OOCYTE PICK-UP AND ASSISTED REPRODUCTIVE TECHNIQUES

Representative Company:

MERCK SARL LIMITED

Manufacturer:

MERCK SARL LIMITED, FRANCE

Applicant:

MERCK SARL LIMITED

Expiry_date:

2022-01-11 00:00:00

Registration / Re-registration:

REG

Products Informtion

---

Name:

DIPHTHERIA,TETANUS,PERTUSSIS,HEPATITIS B AND HAEMOPHILUS INFLUENZAR TYPE B CONJUFATE VACCINE ABSORBED

Registration Date:

2020-08-14 00:00:00

Generic Name:

Strength:

0.5ML/DOSE

Classification:

HIGH RISK

Active Ingredient:

DIPHTHERIA,TETANUS,PERTUSSIS,HEPATITIS B AND HAEMOPHILUS INFLUENZAR TYPE B CONJUFATE VACCINE ABSORBED

Dosage Form Indication:

SOLUTION FOR INJECTION_INDICATED FOR ACTIVE IMMUNIZATION AGAINST DIPHTHERIA, TETANUS, PERTUSIS, HEPATITIS B AND HAEMOPHILUS INFLUENZAE TYPE B INFECTIOUS DISEASES

Representative Company:

M & G PHARMACEUTICALS LTD

Manufacturer:

SERUM INSTITUTE OF INDIA

Applicant:

SERUM INSTITUTE OF INDIA

Expiry_date:

2023-01-09 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

VICTOZA

Registration Date:

2020-09-22 00:00:00

Generic Name:

LIRAGLUTIDE

Strength:

6MG/ML

Classification:

HIGH RISK

Active Ingredient:

LIRAGLUTIDE, GLUCAGON-LIKE PEPTIDE

Dosage Form Indication:

INJECTABLE SOLUTION_INDICATED FOR TREATMENT OF DIABETES ELLITUS TYPE 2 AND OBESITY

Representative Company:

GOKALS-LABOREX LTD

Manufacturer:

NOVO NORDISK A/S (DENMARK)

Applicant:

NOVO NORDISK PHARMA GULF FZ-LLC

Expiry_date:

2023-01-10 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

ENBREL 50 MG (ETANERCEPT)

Registration Date:

2018-08-02 00:00:00

Generic Name:

ETANERCEPT

Strength:

50MG

Classification:

HIGH RISK

Active Ingredient:

ETANERCEPT

Dosage Form Indication:

INJECTABLE SOLUTION_INDICATED FOR MODERATE OR SEVERE RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, SEVERE AXIAL SPONDYLO-ARTHRITIS INCLUDING ANKYLOSING SPONDYLITIS

Representative Company:

GOKALS- LABOREX LTD

Manufacturer:

PFIZER IRELAND PHARMACEUTICALS IRELAND

Applicant:

PFIZER SPECIALTIES GHANA. BOX GP 3542, ACCRA

Expiry_date:

2021-01-03 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

TETRAXIM VACCINE

Registration Date:

2017-11-16 00:00:00

Generic Name:

Strength:

0.5ML/DOSE

Classification:

HIGH RISK

Active Ingredient:

DIPHTHERIA, TETANUS, PERTUSSIS (ACELLULAR COMPONENT), INACTIVATED

Dosage Form Indication:

SOLUTION FOR INJECTION_INDICATED AGAINST DTP(AC)-IPV INFECTIOUS DISEASES.

Representative Company:

GOKALS-LABOREX LTD

Manufacturer:

SANOFI PASTUER

Applicant:

SANOFI PASTUER

Expiry_date:

2020-01-12 00:00:00

Registration / Re-registration:

REG

Products Informtion

---

Name:

TETGLOB B.P 250 I.U (TETANUS IMMUNOGLOBULIN,HUMAN)

Registration Date:

2018-01-25 00:00:00

Generic Name:

TETANUS VACCINE

Strength:

250 I.U

Classification:

HIGH RISK

Active Ingredient:

TETANUS IMMUNOGLOBULIN, HUMAN

Dosage Form Indication:

INJECTABLE SOLUTION_INDICATED AGAINST TETANUS INFECTIOUS DISEASE

Representative Company:

M & G PHARMACEUTICALS LTD

Manufacturer:

BHARAT SERUMS AND VACCINES LIMITED

Applicant:

BHARAT SERUMS AND VACCINES LIMITED

Expiry_date:

2021-01-02 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

BCG VACCINE (10& 20 DOSE)

Registration Date:

2018-01-25 00:00:00

Generic Name:

TUBERCULOSIS VACCINE

Strength:

10 & 20 DOSE

Classification:

HIGH RISK

Active Ingredient:

BACILLE CALMETTE-GUERIN STAIN OF MYCOBACTERIUM BOVIS LIVE, ATENUATED

Dosage Form Indication:

INJECTABLE SOLUTION_INDICATED AGAINST TUBERCULOSIS

Representative Company:

M & G PHARMACEUTICALS LTD

Manufacturer:

SERUM INSTITUTE OF INDIA LIMITED

Applicant:

SERUM INSTITUTE OF INDIA LIMITED

Expiry_date:

2021-01-02 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

PREVENAR 13 SINGLE DOSE

Registration Date:

2018-01-25 00:00:00

Generic Name:

PNEUMOCOCCAL VACCINE

Strength:

0.5ML/DOSE

Classification:

HIGH RISK

Active Ingredient:

PNEUMOCOCCAL 13-VALENT CONJUGATE VACCINE

Dosage Form Indication:

INJECTABLE SOLUTION_ FOR PREVENTION OF PNEUMOCOCCAL PNEUMONIA AND INVASIVE DISEASE CAUSED BY 13 STREPTOCOCCUS PNEUMONIAE STRAINS (STREPTOCOCCUS PNEUMONIAE SEROTYPES 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, AND 23F)

Representative Company:

GOKALS-LABOREX LTD

Manufacturer:

WYETH PHARMACEUTICALS DIVISION, HOLIDAY COOPERATION, USA

Applicant:

PFIZER SPECIALTIES GHANA. BOX GP 3542, ACCRA

Expiry_date:

2021-01-02 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

PREVENAR 13 MULTI DOSE

Registration Date:

2019-06-02 00:00:00

Generic Name:

PNEUMOCOCCAL VACCINE

Strength:

0.5ML/DOSE

Classification:

HIGH RISK

Active Ingredient:

PNEUMOCOCCAL 13-VALENT CONJUGATE VACCINE

Dosage Form Indication:

INJECTABLE SOLUTION_ FOR PREVENTION OF PNEUMOCOCCAL PNEUMONIA AND INVASIVE DISEASE CAUSED BY 13 STREPTOCOCCUS PNEUMONIAE STRAINS (STREPTOCOCCUS PNEUMONIAE SEROTYPES 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, AND 23F)

Representative Company:

GOKALS-LABOREX LTD

Manufacturer:

WYETH PHARMACEUTICALS DIVISION, HOLIDAY COOPERATION, USA

Applicant:

PFIZER SPECIALTIES GHANA. BOX GP 3542, ACCRA

Expiry_date:

2022-01-03 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

REMICADE

Registration Date:

2019-12-17 00:00:00

Generic Name:

INFLIXIMAB

Strength:

100 MG

Classification:

HIGH RISK

Active Ingredient:

INFLIXIMAB

Dosage Form Indication:

POWER AND SOLVENT FOR SOLUTION FOR INJECTION_INDICATED FOR CROHN'S DISEASE, ULCERATIVE COLITIS, RHEUMATOID ARTHRITIS

Representative Company:

ERNEST CHEMISTS LIMITED

Manufacturer:

CILAG AG

Applicant:

JANSSEN PHARMACEUTICA N. V.

Expiry_date:

2022-01-12 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

GARDASIL

Registration Date:

2020-02-24 00:00:00

Generic Name:

HPV VACCINE

Strength:

0.5ML/DOSE

Classification:

HIGH RISK

Active Ingredient:

HUMAN PAPILLOMAVIRUS TYPES 6,11,16 AND 18

Dosage Form Indication:

SUSPENSION FOR INJECTION_INDICATED AGAINST HUMAN PAPILLOMAVIRUS TYPES 6,11,16 AND 18

Representative Company:

WORLDWIDE HEALTHCARE LIMITED

Manufacturer:

MSD BV

Applicant:

MSD (Pty) Limited

Expiry_date:

2023-01-03 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

PENTAXIM

Registration Date:

2019-08-14 00:00:00

Generic Name:

PENTRAXIN

Strength:

0.5ML/DOSE

Classification:

HIGH RISK

Active Ingredient:

DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID (ACELULLAR COMPONET), POLIOMYELITIS VIRUS 1,2,3 (INACTIVATED) AND POLYSACCHARIDE OF HAEMOPHILUS INFLUENZA TYPE B CONJUGATED, ADSORBED

Dosage Form Indication:

INJECTABLE SOLUTION_INDICATED FOR ACTIVE IMMUNIZATION AGAINST DTAP-IPV-HIB INFECTIOUS DISEASES

Representative Company:

GOKALS-LABOREX LTD

Manufacturer:

SANOFI PASTUER

Applicant:

SANOFI PASTUER

Expiry_date:

2022-01-09 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

MENAFRIVAC (10 DOSES VIAL)

Registration Date:

2018-01-25 00:00:00

Generic Name:

MENINGITIS VACCINE

Strength:

0.5ML/DOSE

Classification:

HIGH RISK

Active Ingredient:

POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID (TT)CARRIER PROTEIN.

Dosage Form Indication:

INJECTABLE SOLUTION_INDICATED FOR ACTIVE IMMUNIZATION AGAINST MENINGOCOCCAL DISEASE CAUSED BY NEISSERIA MENINGITIDIS GROUP A.

Representative Company:

M & G PHARMACEUTICALS

Manufacturer:

SERUM INSTITUTE OF INDIA LIMITED

Applicant:

SERUM INSTITUTE OF INDIA LIMITED

Expiry_date:

2021-01-02 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

MENAFRIVAC (5MCG/0.5ML DOSES VIAL)

Registration Date:

2019-11-14 00:00:00

Generic Name:

MENINGITIS VACCINE

Strength:

5MCG/0.5ML DOSES VIAL

Classification:

HIGH RISK

Active Ingredient:

POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID (TT)CARRIER PROTEIN.

Dosage Form Indication:

INJECTABLE SOLUTION_INDICATED FOR ACTIVE IMMUNIZATION AGAINST MENINGOCOCCAL DISEASE CAUSED BY NEISSERIA MENINGITIDIS GROUP A.

Representative Company:

M & G PHARMACEUTICALS

Manufacturer:

SERUM INSTITUTE OF INDIA LIMITED

Applicant:

SERUM INSTITUTE OF INDIA LIMITED

Expiry_date:

2022-01-12 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

RHOCLONE

Registration Date:

2018-03-20 00:00:00

Generic Name:

RHESUS INJECTION

Strength:

300MCG/2ML

Classification:

HIGH RISK

Active Ingredient:

ANTI RHO-D IMMUNOGLOBULIN

Dosage Form Indication:

POWDER AND SOLVENT FOR RECONSTTUTION FOR INJECTION_FOR PREVENTION OF ANTIBODY FORMATION TO FOETAL RHESUS POSITIVE RED BLOOD CELLS IN RHO-D NEGATIVE WOMEN

Representative Company:

M & G PHARMACEUTICALS

Manufacturer:

BHARAT SERUMS AND VACCINES LIMITED

Applicant:

BHARAT SERUMS AND VACCINES LIMITED

Expiry_date:

2021-01-04 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

SPEEDA RABIES VACCINE

Registration Date:

2018-11-04 00:00:00

Generic Name:

RABIES VACCINE

Strength:

GREATER OR EQUAL TO 2.5 I.U

Classification:

HIGH RISK

Active Ingredient:

HUMAN SERUM ALBUMIN OF RABIES ANTIGEN

Dosage Form Indication:

POWDER(LYOPHILIZED) AND SOLVENT FOR RECONSTITUTION FOR INJECTION_INDICATED FOR THE PREVENTION OF RABIES IN SUBJECTS AT A HIGH RISK OF EXPOSURE

Representative Company:

GRAYS PHARMACY LIMITED

Manufacturer:

LIAONING CHENG BIOTECHNOLOGY COMPANY LIMITED

Applicant:

LIAONING CHENG BIOTECHNOLOGY COMPANY LIMITED

Expiry_date:

2021-01-05 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

PANAF-PREMIUM

Registration Date:

2018-04-28 00:00:00

Generic Name:

SNAKE ANTI-VENOM

Strength:

1ML/DOSE

Classification:

HIGH RISK

Active Ingredient:

EQUINE IMMUNOGLOBULIN FRAGMENTS

Dosage Form Indication:

POWDER AND SOLVENT FOR RECONSTITUTION FOR INJECTION_INDICATED AGAINST SNAKE BITES

Representative Company:

AS-TESCO INVESTMENT CO.LTD

Manufacturer:

PREMIUM SERUMS AND VACCINES LTD

Applicant:

PREMIUM SERUMS AND VACCINES LTD

Expiry_date:

2021-01-05 00:00:00

Registration / Re-registration:

1/5/2019

Products Informtion

---

Name:

GONAL F 300 I.U

Registration Date:

2018-02-16 00:00:00

Generic Name:

FOLLITROPIN ALFA

Strength:

300 I.U/0.5ML

Classification:

HIGH RISK

Active Ingredient:

FOLLITROPIN ALFA

Dosage Form Indication:

INJECTABLE SOLUTION_INDICATED FOR THE INDUCTION OF OVULATION AND PREGNANCY IN THE ANOVULATORY INFERTILE PATIENTS WHOM THE CAUSE OF INFERTILITY IS FUNCTIONAL AND NOT DUE TO PRIMARY OVARIAN FAILURE.

Representative Company:

MERCK SARL LIMITED

Manufacturer:

MERCK SERONO ZONE INDUSTRIELLE

Applicant:

MERCK SARL LIMITED

Expiry_date:

2021-01-06 00:00:00

Registration / Re-registration:

REG

Products Informtion

---

Name:

GONAL F 450 I.U

Registration Date:

2018-02-16 00:00:00

Generic Name:

FOLLITROPIN ALFA

Strength:

450 I.U/0.75ML

Classification:

HIGH RISK

Active Ingredient:

FOLLITROPIN ALFA

Dosage Form Indication:

INJECTABLE SOLUTION_GONAL F IS INDICATED FOR THE INDUCTION OF OVULATION AND PREGNANCY IN THE ANOVULATORY INFERTILE PATIENTS WHOM THE CAUSE OF INFERTILITY IS FUNCTIONAL AND NOT DUE TO PRIMARY OVARIAN FAILURE.

Representative Company:

MERCK SARL LIMITED

Manufacturer:

MERCK SERONO ZONE INDUSTRIELLE

Applicant:

MERCK SARL LIMITED

Expiry_date:

2021-01-06 00:00:00

Registration / Re-registration:

REG

Products Informtion

---

Name:

GONAL F 900 I.U

Registration Date:

2018-02-16 00:00:00

Generic Name:

FOLLITROPIN ALFA

Strength:

900I.U/1.5ML

Classification:

HIGH RISK

Active Ingredient:

FOLLITROPIN ALFA

Dosage Form Indication:

INJECTABLE SOLUTION_INDICATED FOR THE INDUCTION OF OVULATION AND PREGNANCY IN THE ANOVULATORY INFERTILE PATIENTS WHOM THE CAUSE OF INFERTILITY IS FUNCTIONAL AND NOT DUE TO PRIMARY OVARIAN FAILURE.

Representative Company:

MERCK SARL LIMITED

Manufacturer:

MERCK SERONO ZONE INDUSTRIELLE

Applicant:

MERCK SARL LIMITED

Expiry_date:

2021-01-06 00:00:00

Registration / Re-registration:

REG

Products Informtion

---

Name:

LANTUS SOLOSTAR

Registration Date:

2018-03-26 00:00:00

Generic Name:

INSULIN

Strength:

100 I.U/ML

Classification:

HIGH RISK

Active Ingredient:

INSULIN GLARGINE

Dosage Form Indication:

INJECTABLE SOLUTION_FOR DIABETES TREATMENT

Representative Company:

GOKALS-LABOREX LTD

Manufacturer:

SANOFI- AVENTIS DEUTSCHLAND GmbH

Applicant:

SANOFI AVENTIS NIGERIA LIMITED

Expiry_date:

2021-01-04 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

LANTUS SOLUTION FOR INJECTION IN A CATRIDGE

Registration Date:

2019-11-15 00:00:00

Generic Name:

INSULIN

Strength:

100 I.U/ML

Classification:

HIGH RISK

Active Ingredient:

INSULIN GLARGINE

Dosage Form Indication:

INJECTABLE SOLUTION_FOR DIABETES TREATMENT

Representative Company:

GOKALS-LABOREX LTD

Manufacturer:

SANOFI- AVENTIS DEUTSCHLAND GmbH

Applicant:

SANOFI AVENTIS NIGERIA LIMITED

Expiry_date:

2022-01-12 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

ROTARIX VACCINE

Registration Date:

2018-06-29 00:00:00

Generic Name:

ROTAVIRUS VACCINE

Strength:

2 ML/DOSE

Classification:

HIGH RISK

Active Ingredient:

HUMAN ROTAVIRUS OUTER SURFACE PROTEIN REASSORTANT G1, G2, G3, G4, P1A[8] STRAIN, LIVE, ATTENUATED

Dosage Form Indication:

ORAL SOLUTION_INDICATED FOR THE PREVENTION OF ROTAVIRUS GASTROENTERITIS CAUSED BY G1 AND NON-G1 TYPES (G3, G4, AND G9) WHEN ADMINISTERED AS A 2-DOSE SERIES IN INFANTS AND CHILDREN

Representative Company:

GOKALS-LABOREX LTD

Manufacturer:

MERCK SHARP & DOHME CORP.

Applicant:

MSD IDEA PHARMACEUTICALS

Expiry_date:

2023-01-07 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

HEPATITIS B VACCINE (rDNA) (PAEDIATRIC)

Registration Date:

2018-06-29 00:00:00

Generic Name:

HEPTITIS B VACCINE

Strength:

0.5 ML/DOSE

Classification:

HIGH RISK

Active Ingredient:

HEPATITIS B SURFACE ANTIGEN

Dosage Form Indication:

INJECTABLE SUSPENSION_INDICATED FOR ACTIVE IMMUNIZATION AGAINST HEPATITIS B INFECTION IN SUBJECTS AT RISK TO THE DISEASES

Representative Company:

M & G PHARMACEUTICALS LTD

Manufacturer:

SERUM INSTITUTE OF INDIA

Applicant:

SERUM INSTITUTE OF INDIA

Expiry_date:

2021-01-08 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

HEPATITIS B VACCINE (rDNA) (ADULT)

Registration Date:

2018-06-29 00:00:00

Generic Name:

HEPATITIS VACCINE

Strength:

1 ML/DOSE

Classification:

HIGH RISK

Active Ingredient:

HEPATITIS B SURFACE ANTIGEN

Dosage Form Indication:

INJECTABLE SUSPENSION_INDICATED FOR ACTIVE IMMUNIZATION AGAINST HEPATITIS B INFECTION IN SUBJECTS AT RISK TO THE DISEASES

Representative Company:

M & G PHARMACEUTICALS LTD

Manufacturer:

SERUM INSTITUTE OF INDIA

Applicant:

SERUM INSTITUTE OF INDIA

Expiry_date:

2021-01-08 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

TRESIBA FLEXTOUCH (1x5x3ml)

Registration Date:

2019-11-03 00:00:00

Generic Name:

INSULIN DEGLUDEC

Strength:

100 I.U

Classification:

HIGH RISK

Active Ingredient:

INSULIN DEGLUDEC

Dosage Form Indication:

INJECTABLE SOLUTION_INDICATED FOR DIABETES TREATMENT

Representative Company:

GOKALS-LABOREX LTD

Manufacturer:

NOVO NORDISK A/S (DENMARK)

Applicant:

NOVO NORDISK PHARMA GULF FZ-LLC

Expiry_date:

2022-01-03 00:00:00

Registration / Re-registration:

REG

Products Informtion

---

Name:

MIRCERA

Registration Date:

2020-06-20 00:00:00

Generic Name:

EPOEITIN INJECTION

Strength:

75 MICROGRAMS/ 0.3ML

Classification:

HIGH RISK

Active Ingredient:

METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA

Dosage Form Indication:

INJECTABLE SOLUTION_FOR TREATMENT OF SYMPTOMATIC ANAEMIA ASSOCIATED WITH CHRONIC KIDNEY DISEASE (CKD) IN ADULT PATIENTS

Representative Company:

F. HOFFMAN LA-ROCHE GHANA LTD

Manufacturer:

F. HOFFMANN-LA ROCHE LTD.(Switzerland)

Applicant:

F. HOFFMANN-LA ROCHE LTD.(Switzerland)

Expiry_date:

2021-01-07 00:00:00

Registration / Re-registration:

Products Informtion

---

Name:

FOLIGRAF 75I.U

Registration Date:

2018-05-17 00:00:00

Generic Name:

UROFOLLITROPIN

Strength:

75 I.U

Classification:

HIGH RISK

Active Ingredient:

RECOMBINANT HUMAN FOLLICLE STIMULATING HORMONE

Dosage Form Indication:

POWDER AND SOLVENT FOR SOLUTION FOR INJECTION_FOR TREATMENT OF INFERTILITY IN WOMEN. IT IS ALSO HELPFUL IN THE TREATMENT OF MALE HYPOGONADISM (DELAYED PUBERTY , AND LOW SPERM COUNT). IT WORKS BY RELEASING THE EGGS FROM THE OVARY IN WOMEN AND BY INCREASING THE TESTOSTERONE LEVEL IN MEN

Representative Company:

M & G PHARMACEUTICALS

Manufacturer:

BHARAT SERUMS AND VACCINES LIMITED

Applicant:

BHARAT SERUMS AND VACCINES LIMITED

Expiry_date:

2021-01-06 00:00:00

Registration / Re-registration:

REG

Products Informtion

---

Name:

FOLIGRAF 150I.U

Registration Date:

2018-05-17 00:00:00

Generic Name:

UROFOLLITROPIN

Strength:

150 I.U

Classification:

HIGH RISK

Active Ingredient:

RECOMBINANT HUMAN FOLLICLE STIMULATING HORMONE

Dosage Form Indication:

POWDER AND SOLVENT FOR SOLUTION FOR INJECTION_FOR TREATMENT OF INFERTILITY IN WOMEN. IT IS ALSO HELPFUL IN THE TREATMENT OF MALE HYPOGONADISM (DELAYED PUBERTY , AND LOW SPERM COUNT). IT WORKS BY RELEASING THE EGGS FROM THE OVARY IN WOMEN AND BY INCREASING THE TESTOSTERONE LEVEL IN MEN

Representative Company:

M & G PHARMACEUTICALS

Manufacturer:

BHARAT SERUMS AND VACCINES LIMITED

Applicant:

BHARAT SERUMS AND VACCINES LIMITED

Expiry_date:

2021-01-06 00:00:00

Registration / Re-registration:

REG

Products Informtion

---

Name:

POLIO SABIN ONE AND THREE (ORAL BIVALENT POLIOMYELITIS VACCINE TYPES 1 AND 3 LIVE, ATENUATED)

Registration Date:

2020-01-31 00:00:00

Generic Name:

POLIO VACCINE

Strength:

0.5ML/DOSE

Classification:

HIGH RISK

Active Ingredient:

POLIO VIRUSES (SABIN STRAINS), LIVE ATTENUATED TYPES 1 & 3

Dosage Form Indication:

ORAL SOLUTION_FOR ACTIVE IMMUNIZATION IN ALL AGE GROUPS AGAINST INFECTION CAUSED BY POLIOMYELITIS VIRUSES OF TYPE 1 AND 3

Representative Company:

WORLDWIDE HEALTHCARE LIMITED

Manufacturer:

GLAXOSMITHKLINE BIOLOGICALS S. A.

Applicant:

GLAXOSMITHKLINE BIOLOGICALS S. A.

Expiry_date:

2023-01-02 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

ERVEBO-EBOLA ZAIRE VACCINE

Registration Date:

2020-07-02 00:00:00

Generic Name:

EBOLA VACCINE

Strength:

1ML/DOSE

Classification:

HIGH RISK

Active Ingredient:

rVSV-ZEBOV, LIVE, ATENUATED

Dosage Form Indication:

SOLUTION FOR INJECTION_INDICATED FOR ACTIVE IMMUNIZATION AGAINST EBOLA VIRUS INFECTION

Representative Company:

WORLDWIDE HEALTHCARE LIMITED

Manufacturer:

GLAXOSMITHKLINE BIOLOGICALS S. A.

Applicant:

GLAXOSMITHKLINE BIOLOGICALS S. A.

Expiry_date:

2021-01-03 00:00:00

Registration / Re-registration:

REG

Products Informtion

---

Name:

ACTRAPID PENFIL

Registration Date:

2018-03-08 00:00:00

Generic Name:

HUMAN INSULIN

Strength:

100 I. U./ML

Classification:

HIGH RISK

Active Ingredient:

INSULIN HUMAN (rDNA)

Dosage Form Indication:

SOLUTION FOR INJECTION_FOR TREATMENT OF DIABETES MELLITUS

Representative Company:

GOKALS-LABOREX LTD

Manufacturer:

NOVO NORDISK A/S (DENMARK)

Applicant:

NOVO NORDISK PHARMA GULF FZ-LLC

Expiry_date:

2021-01-09 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

MEASLES AND RUBELLA

Registration Date:

2020-08-14 00:00:00

Generic Name:

MEASELS VACCINE

Strength:

0.5ML/DOSE

Classification:

HIGH RISK

Active Ingredient:

MEASLES AND RUBELLA VIRUS, LIVE, ATTENUATED

Dosage Form Indication:

POWDER AND SOLVENT FOR SOLUTION FOR INJECTION_FOR ACTIVE IMMUNIZATION AGAINST MEASLES AND RUBELLA INFECTIOUS DISEASES

Representative Company:

M & G PHARMACEUTICALS

Manufacturer:

SERUM INSTITUTE OF INDIA

Applicant:

SERUM INSTITUE OF INDIA

Expiry_date:

2023-01-09 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

INSUGEN-R

Registration Date:

2020-05-03 00:00:00

Generic Name:

SOLUBLE INSULIN

Strength:

100 I.U

Classification:

HIGH RISK

Active Ingredient:

SOLUBLE INSULIN

Dosage Form Indication:

INJECTABLE SOLUTION_FOR TREATMENT OF DIABETIS MELLITUS

Representative Company:

ALPHA DUO PHARMA LIMITED. P. O. BOX 3156, ADUM KUMASI, GHANA

Manufacturer:

BIOCON LIMITED

Applicant:

BIOCON LIMITED

Expiry_date:

2023-01-04 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

INSUGEN-N (NPH)

Registration Date:

2020-05-03 00:00:00

Generic Name:

INSULIN

Strength:

100 I.U

Classification:

HIGH RISK

Active Ingredient:

INSULIN ISOPHANE

Dosage Form Indication:

INJECTABLE SUSPENSION_FOR TREATMENT OF DIABETIS MELLITUS

Representative Company:

ALPHA DUO PHARMA LIMITED. P. O. BOX 3156, ADUM KUMASI, GHANA

Manufacturer:

BIOCON LIMITED

Applicant:

BIOCON LIMITED

Expiry_date:

2023-01-04 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

INSUGEN-30/70 (BIPHASIC)

Registration Date:

2020-05-03 00:00:00

Generic Name:

INSULIN

Strength:

100 I.U

Classification:

HIGH RISK

Active Ingredient:

INSULIN BIPHASIC ISOPHANE

Dosage Form Indication:

INJECTABLE SUSPENSION_FOR TREATMENT OF DIABETIS MELLITUS

Representative Company:

ALPHA DUO PHARMA LIMITED. P. O. BOX 3156, ADUM KUMASI, GHANA

Manufacturer:

BIOCON LIMITED

Applicant:

BIOCON LIMITED

Expiry_date:

2023-01-04 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

OVITRELLE

Registration Date:

2018-06-28 00:00:00

Generic Name:

CHORIOGONADOTROPIN

Strength:

250MG/0.5ML

Classification:

HIGH RISK

Active Ingredient:

CHORIOGONADOTROPIN ALFA

Dosage Form Indication:

INJECTABLE SOLUTION_FOR ASSISTED REPRODUCTIVE TECHNIQUES

Representative Company:

MERCK SARL LIMITED 60 LIBERATION ROAD, HORIZON BUILDING, 1ST FLOOR RM3 AIRPORT

Manufacturer:

MERCK S. P.A VIADELLE MAGNOLIA 15 ZONE INDUSTRIALE 70026 MADUGNO ITALY AND MERCK SERONO S.A SUCCURSALE D AUBONNE ZONE INDUSTRIELE DE IOURIETTAZ CH-1170, AUBONNE SWITZERLAND

Applicant:

MERCK SARL LIMITED 60 LIBERATION ROAD, HORIZON BUILDING, 1ST FLOOR RM3 AIRPORT

Expiry_date:

2021-01-07 00:00:00

Registration / Re-registration:

REG

Products Informtion

---

Name:

TETANUS ANTITOXIN B.P

Registration Date:

2020-08-14 00:00:00

Generic Name:

TETANUS VACCINE

Strength:

1500 I.U

Classification:

HIGH RISK

Active Ingredient:

TETANUS ANTITOXIN

Dosage Form Indication:

INJECTABLE SOLUTION_INDICATED FOR THE TREATMENT OF TETANUS INFECTION

Representative Company:

M & G PHARMACEUTICALS LTD

Manufacturer:

BHARAT SERUMS AND VACCINES LIMITED

Applicant:

BHARAT SERUMS AND VACCINES LIMITED

Expiry_date:

2023-01-09 00:00:00

Registration / Re-registration:

REG

Products Informtion

---

Name:

BEAFRIQUE-10

Registration Date:

2020-06-18 00:00:00

Generic Name:

SNAKE ANTI-VENOM

Strength:

10ML/DOSE

Classification:

HIGH RISK

Active Ingredient:

ANTI SNAKE VENOM SERUM-PAN AFRICAN(10) POLYVALENT, ENZYME REFINED, EQUINE IMMUNOGLOBULIN

Dosage Form Indication:

SOLUTION FOR INJECTION_INDICATED FOR THE TREATMENT OF SNAKE BITE

Representative Company:

ASVA BIOLOGICALS LIMITED, 903 PAINTSIWA, DR ESTHER OCLOO STREET OSU, ACCRA

Manufacturer:

BIOLOGICALS E.LIMITED. PLOT NO. 623H ROAD NO 35, JUBILEE HILLS HYDERABAD 500033, INDIA

Applicant:

BIOLOGICALS E.LIMITED. PLOT NO. 623H ROAD NO 35, JUBILEE HILLS HYDERABAD 500033, INDIA

Expiry_date:

2022-01-06 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

INSUMAN RAPID (VIAL)

Registration Date:

2020-06-17 00:00:00

Generic Name:

HUMAN INSULIN

Strength:

100 I.U

Classification:

HIGH RISK

Active Ingredient:

HUMAN INSULIN

Dosage Form Indication:

INJECTABLE SOLUTION_ANTI DIABETIC AGENT

Representative Company:

GOKALS-LABOREX LTD

Manufacturer:

SANOFI- AVENTIS DEUTSCHLAND GmbH

Applicant:

SANOFI AVENTIS NIGERIA LIMITED

Expiry_date:

2021-01-08 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

HAVRIX 720 PAEDIATRIC

Registration Date:

2018-11-04 00:00:00

Generic Name:

HEPATITIS A VACCINE

Strength:

0.5ML/DOSE

Classification:

HIGH RISK

Active Ingredient:

HEPATITIS A VIRUS (HM175 STRAIN), INACTIVATED

Dosage Form Indication:

INJECTABLE SUSPENSION_INDICATED FOR ACTIVE IMMUNIZATION AGAINST HEPATITIS A INFECTION IN CHILDREN AT RISK

Representative Company:

WORLDWIDE HEALTHCARE LIMITED

Manufacturer:

GLAXOSMITHKLINE BIOLOGICALS S. A.

Applicant:

GLAXOSMITHKLINE BIOLOGICALS S. A.

Expiry_date:

2021-01-05 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

TETANUS TOXOID VACCINE

Registration Date:

2018-12-17 00:00:00

Generic Name:

TETANUS VACCINE

Strength:

0.5ML/DOSE

Classification:

HIGH RISK

Active Ingredient:

TETANUS TOXOID ADSORBED

Dosage Form Indication:

INJECTABLE SOLUTION_INDICATED FOR THE PREVENTION OF TETANUS INFECTION IN INFANTS, CHILDREN AND ADULTS

Representative Company:

M & G PHARMACEUTICALS LTD

Manufacturer:

SERUM INSTITUTE OF INDIA

Applicant:

SERUM INSTITUTE OF INDIA

Expiry_date:

2021-01-01 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

TETANUS TOXOID VACCINE

Registration Date:

2018-12-17 00:00:00

Generic Name:

TETANUS VACCINE

Strength:

5ML/DOSE

Classification:

HIGH RISK

Active Ingredient:

TETANUS TOXOID ABSORBED

Dosage Form Indication:

INJECTABLE SOLUTION_INDICATED FOR THE PREVENTION OF TETANUS INFECTION IN INFANTS, CHILDREN AND ADULTS

Representative Company:

M & G PHARMACEUTICALS LTD

Manufacturer:

SERUM INSTITUTE OF INDIA

Applicant:

SERUM INSTITUTE OF INDIA

Expiry_date:

2021-01-01 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

TETANUS TOXOID VACCINE

Registration Date:

2018-12-17 00:00:00

Generic Name:

TETANUS VACCINE

Strength:

10ML/DOSE

Classification:

HIGH RISK

Active Ingredient:

TETANUS TOXOID ABSORBED

Dosage Form Indication:

INJECTABLE SOLUTION_INDICATED FOR THE PREVENTION OF TETANUS INFECTION IN INFANTS, CHILDREN AND ADULTS

Representative Company:

M & G PHARMACEUTICALS LTD

Manufacturer:

SERUM INSTITUTE OF INDIA

Applicant:

SERUM INSTITUTE OF INDIA

Expiry_date:

2021-01-01 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

INSUMAN COMB 30 CARTRIDGE

Registration Date:

2019-07-17 00:00:00

Generic Name:

HUMAN INSULIN

Strength:

100 I.U/ML

Classification:

HIGH RISK

Active Ingredient:

HUMAN INSULIN

Dosage Form Indication:

INJECTABLE SUSPENSION_ANTI DIABETIC AGENT

Representative Company:

GOKALS-LABOREX LTD

Manufacturer:

SANOFI- AVENTIS DEUTSCHLAND GmbH

Applicant:

SANOFI AVENTIS NIGERIA LIMITED

Expiry_date:

2021-01-08 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

INSUMAN COMB 30 VIAL

Registration Date:

2020-07-17 00:00:00

Generic Name:

HUMAN INSULIN

Strength:

100 I.U/ML

Classification:

HIGH RISK

Active Ingredient:

HUMAN INSULIN

Dosage Form Indication:

INJECTABLE SUSPENSION_ANTI DIABETIC AGENT

Representative Company:

GOKALS-LABOREX LTD

Manufacturer:

SANOFI- AVENTIS DEUTSCHLAND GmbH

Applicant:

SANOFI AVENTIS NIGERIA LIMITED

Expiry_date:

2021-01-08 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

HEPATECT CP

Registration Date:

2018-02-26 00:00:00

Generic Name:

HEPATITIS B IMMUNOGLOBIN

Strength:

50 I.U/ML

Classification:

HIGH RISK

Active Ingredient:

HUMAN HEPATITIS B IMMUNOGLOBULIN

Dosage Form Indication:

INJECTABLE SOLUTION_FOR PREVENTION OF HEPATITIS B VIRUS RE-INFECTION AFTER LIVER TRANSPLANTATION FOR HEPATITIS B INDUCED LIVER FAILURE

Representative Company:

CRESENT CHEMIST

Manufacturer:

BIOTEST PHARMA GmbH

Applicant:

BIOTEST PHARMA GmbH

Expiry_date:

2021-01-11 00:00:00

Registration / Re-registration:

REG

Products Informtion

---

Name:

FOVEPTA

Registration Date:

2019-02-26 00:00:00

Generic Name:

HEPATITIS B IMMUNOGLOBIN

Strength:

200I.U/0.4ML

Classification:

HIGH RISK

Active Ingredient:

HUMAN HEPATITIS B IMMUNOGLOBULIN

Dosage Form Indication:

INJECTABLE SOLUTION_IMMUNOPROPHYLAXIS OF HEPATITIS B IN THE NEWBORN OF A HEPATITIS B VIRUS CARRIER MOTHER

Representative Company:

CRESENT CHEMIST

Manufacturer:

BIOTEST PHARMA GmbH

Applicant:

BIOTEST PHARMA GmbH

Expiry_date:

2021-01-11 00:00:00

Registration / Re-registration:

REG

Products Informtion

---

Name:

TRESIBA FLEXTOUCH (1x3x3ml)

Registration Date:

2019-11-03 00:00:00

Generic Name:

ISULIJN DEGLUDEC

Strength:

100 I.U

Classification:

HIGH RISK

Active Ingredient:

INSULIN DEGLUDEC

Dosage Form Indication:

INJECTABLE SOLUTION_INDICATED FOR DIABETES TREATMENT

Representative Company:

GOKALS-LABOREX LTD

Manufacturer:

NOVO NORDISK A/S (DENMARK)

Applicant:

NOVO NORDISK PHARMA GULF FZ-LLC

Expiry_date:

2022-01-04 00:00:00

Registration / Re-registration:

REG

Products Informtion

---

Name:

HERCEPTIN IV

Registration Date:

2019-11-03 00:00:00

Generic Name:

TRASTUZUMAB

Strength:

150 MG

Classification:

HIGH RISK

Active Ingredient:

TRASTUZUMAB

Dosage Form Indication:

INJECTABLE SOLUTION_FOR TREATMENT OF BREAST CANCER

Representative Company:

F. HOFFMAN LA-ROCHE GHANA LTD

Manufacturer:

F. HOFFMANN-LA ROCHE LTD.(Switzerland)

Applicant:

F. HOFFMAN LA-ROCHE GHANA LTD

Expiry_date:

2022-01-04 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

HERCEPTIN IV

Registration Date:

2019-11-03 00:00:00

Generic Name:

TRASTUZUMAB

Strength:

440 MG

Classification:

HIGH RISK

Active Ingredient:

TRASTUZUMAB

Dosage Form Indication:

INJECTABLE SOLUTION_FOR TREATMENT OF BREAST CANCER

Representative Company:

F. HOFFMAN LA-ROCHE GHANA LTD

Manufacturer:

F. HOFFMANN-LA ROCHE LTD.(Switzerland)

Applicant:

F. HOFFMAN LA-ROCHE GHANA LTD

Expiry_date:

2022-01-04 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

PEGASYS PREFILLED

Registration Date:

2019-05-28 00:00:00

Generic Name:

PEGINTEFERON ALPFA-2A

Strength:

180UG/ 0.5 ML

Classification:

HIGH RISK

Active Ingredient:

PEGINTERFERON ALFA-2A

Dosage Form Indication:

INJECTABLE SOLUTION-FOR TREATMENT OF BREAST CANCER

Representative Company:

F. HOFFMAN LA-ROCHE GHANA LTD ROCHE LIMITED

Manufacturer:

F. HOFFMANN-LA ROCHE LTD.(Switzerland)

Applicant:

F. HOFFMANN-LA ROCHE LTD.(Switzerland)

Expiry_date:

2022-01-06 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

CLEXANE

Registration Date:

2019-02-20 00:00:00

Generic Name:

ENOXAPARIN

Strength:

2000 I.U

Classification:

HIGH RISK

Active Ingredient:

ENOXAPARINE SODIUM

Dosage Form Indication:

INJECTABLE SOLUTION_ANTICOAGULANT

Representative Company:

GOKALS-LABOREX LTD

Manufacturer:

SANOFI AVENTIS NIGERIA LTD

Applicant:

SANOFI WINTHROP INDUSTRIE

Expiry_date:

2022-01-03 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

CLEXANE

Registration Date:

2019-02-20 00:00:00

Generic Name:

ENOXAPARIN

Strength:

6000 I.U

Classification:

HIGH RISK

Active Ingredient:

ENOXAPARINE SODIUM

Dosage Form Indication:

INJECTABLE SOLUTION_ANTICOAGULANT

Representative Company:

GOKALS-LABOREX LTD

Manufacturer:

SANOFI AVENTIS NIGERIA LTD

Applicant:

SANOFI WINTHROP INDUSTRIE

Expiry_date:

2022-01-03 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

CLEXANE

Registration Date:

2019-02-20 00:00:00

Generic Name:

ENOXAPARIN

Strength:

8000 I.U

Classification:

HIGH RISK

Active Ingredient:

ENOXAPARINE SODIUM

Dosage Form Indication:

INJECTABLE SOLUTION_ANTICOAGULANT

Representative Company:

GOKALS-LABOREX LTD

Manufacturer:

SANOFI AVENTIS NIGERIA LTD

Applicant:

SANOFI WINTHROP INDUSTRIE

Expiry_date:

2022-01-03 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

IMOVAX POLIO VACCINE

Registration Date:

2019-08-14 00:00:00

Generic Name:

POLIO VACCINE

Strength:

0.5ML/DOSE

Classification:

HIGH RISK

Active Ingredient:

POLIOMYELITIS VIRUS TYPES 1,2 AND, INACTIVATED

Dosage Form Indication:

INJECTABLE SUSPENSION_INDICATED FOR POLIOMYELITIS PROPHYLAXIS IN INFANTS, CHILDREN AND ADULTS FOR PRIMARY VACCINATION AGAINST POLIO AND AS A BOOSTER

Representative Company:

GOKALS-LABOREX LTD

Manufacturer:

SANOFI - PASTEUR S.A.

Applicant:

SANOFI - PASTEUR S.A.

Expiry_date:

2022-01-09 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

EYLEA

Registration Date:

2019-05-28 00:00:00

Generic Name:

AFLIBERCEPT

Strength:

40MG

Classification:

HIGH RISK

Active Ingredient:

AFLIBERCEPT

Dosage Form Indication:

INJECTABLE SOLUTION_INDICATED FOR TREATMENT OF METASTATIC COLORECTAL CANCER

Representative Company:

BAYER WEST- CENTRAL AFRICA S.A, ACCRA

Manufacturer:

BAYER AG MULLARTRASSE, BERLIN

Applicant:

BAYER WEST- CENTRAL AFRICA S.A, ACCRA

Expiry_date:

2022-01-07 00:00:00

Registration / Re-registration:

REG

Products Informtion

---

Name:

INSUMAN BASAL CARTRIDGE

Registration Date:

2020-05-03 00:00:00

Generic Name:

INSULIN HUMAN

Strength:

100 UNITS/ML

Classification:

HIGH RISK

Active Ingredient:

HUMAN INSULIN

Dosage Form Indication:

INJECTABLE SUSPENSION_FOR TREATMENT OF DIABETIS MELLITUS

Representative Company:

GOKALS-LABOREX LTD

Manufacturer:

SANOFI- AVENTIS DEUTSCHLAND GmbH

Applicant:

SANOFI- AVENTIS DEUTSCHLAND GmbH

Expiry_date:

2023-01-04 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

CLEXANE

Registration Date:

2019-06-13 00:00:00

Generic Name:

ENOXAPARIN

Strength:

4000 I.U

Classification:

HIGH RISK

Active Ingredient:

ENOXAPARINE SODIUM

Dosage Form Indication:

INJECTABLE SOLUTION_ANTICOAGULANT

Representative Company:

GOKALS-LABOREX LTD

Manufacturer:

SANOFI AVENTIS NIGERIA LTD

Applicant:

SANOFI WINTHROP INDUSTRIE

Expiry_date:

2022-01-07 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

RABIVAX-S

Registration Date:

2019-05-16 00:00:00

Generic Name:

RABIES VACCINE

Strength:

? 2.5 I.U

Classification:

HIGH RISK

Active Ingredient:

RABIES VACCINE ANTIGEN, INACTIVATED

Dosage Form Indication:

POWDER AND SOLVENT FOR SOLUTION FOR INJECTION_FOR ACTIVE IMMUNIZATION AGAINST RABIES

Representative Company:

M & G PHARMACEUTICALS LTD

Manufacturer:

SERUM INSTITUTE OF INDIA PVT LIMITED

Applicant:

SERUM INSTITUTE OF INDIA PVT LIMITED

Expiry_date:

2022-01-06 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

AFRIVEN-10

Registration Date:

2019-05-30 00:00:00

Generic Name:

SNAKE ANTI-VENOM

Strength:

1ML/DOSE

Classification:

HIGH RISK

Active Ingredient:

SNAKE VENOM ANTISERUM AFRICAN, I.H.S

Dosage Form Indication:

POWDER AND SOLVENT FOR SOLUTION FOR INJECTION_INDICATED FOR TREATMENT OF SNAKE BITES

Representative Company:

PHARMANOVA LIMITED

Manufacturer:

VINS BIOPRODUCTS LIMITED

Applicant:

VINS BIOPRODUCTS LIMITED

Expiry_date:

2022-01-06 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

FRAGMIN

Registration Date:

2019-05-30 00:00:00

Generic Name:

DALTEPARIN

Strength:

2500 I.U

Classification:

HIGH RISK

Active Ingredient:

DALTEPARIN

Dosage Form Indication:

INJECTABLE SOLUTION_ANTICOAGULANT

Representative Company:

PFIZER SPECIALTIES GHANA, 7 BARNES ROAD, FARRAR AVENUE, ADABRAKA. P. O. BOX GP 3542 ACCRA

Manufacturer:

PFIZER MANUFACTURING BELGIUM NV, RIJWEG 12 , 2870 PUURS BELGIQUE

Applicant:

PFIZER SPECIALTIES. GHANA

Expiry_date:

2022-01-11 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

FRAGMIN

Registration Date:

2020-09-30 00:00:00

Generic Name:

DALTEPARIN

Strength:

5000I.U

Classification:

HIGH RISK

Active Ingredient:

DALTEPARIN

Dosage Form Indication:

INJECTABLE SOLUTION_ANTICOAGULANT

Representative Company:

PFIZER SPECIALTIES GHANA, 7 BARNES ROAD, FARRAR AVENUE, ADABRAKA. P. O. BOX GP 3542 ACCRA

Manufacturer:

PFIZER MANUFACTURING BELGIUM NV, RIJWEG 12 , 2870 PUURS BELGIQUE

Applicant:

PFIZER SPECIALTIES. GHANA

Expiry_date:

2022-01-11 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

EQUIRAB

Registration Date:

2019-08-14 00:00:00

Generic Name:

HORSE VACCINE

Strength:

1000 I.U

Classification:

HIGH RISK

Active Ingredient:

EQUINE ANTIRABIES IMMUNOGLOBULIN (RABIES ANTISERUM-EQUINE)

Dosage Form Indication:

INJECTABLE SOLUTION_INDICATED FOR PASSIVE IMMUNIZATION AGAINST RABIES

Representative Company:

M & G PHARMACEUTICALS LIMITED

Manufacturer:

BHARAT SERUMS AND VACCINES LIMITED

Applicant:

BHARAT SERUMS AND VACCINES LIMITED

Expiry_date:

2022-01-09 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

INDIRAB VACCINE

Registration Date:

2018-04-26 00:00:00

Generic Name:

RABIES VACCINE

Strength:

GREATER OR EQUAL TO 2.5 I.U

Classification:

HIGH RISK

Active Ingredient:

RABIES VIRUS INACTIVATED

Dosage Form Indication:

POWDER (LYOPHILIZED) FOR RECONSTITUTION FOR INJECTION_INDICATED FOR THE PREVENTION OF RABIES IN SUBJECTS AT A HIGH RISK OF EXPOSURE

Representative Company:

AS-TESCO INVESTMENT CO.LTD

Manufacturer:

Bharat Biotech International Limited

Applicant:

Bharat Biotech International Limited

Expiry_date:

2021-01-05 00:00:00

Registration / Re-registration:

REG

Products Informtion

---

Name:

ROTAVAC VACCINE

Registration Date:

2019-09-12 00:00:00

Generic Name:

ROTAVIRUS VACCINE

Strength:

0.5ML DOSE, 2.5ML DOSE, 5.0ML DOSE

Classification:

HIGH RISK

Active Ingredient:

ROTAVIRUS LIVE, ATENUATED

Dosage Form Indication:

LIQUID SOLUTION_INDICATED FOR PREVENTION OF ROTAVIRUS INFECTION

Representative Company:

AS-TESCO INVESTMENT CO.LTD

Manufacturer:

Bharat Biotech International Limited

Applicant:

Bharat Biotech International Limited

Expiry_date:

2021-01-01 00:00:00

Registration / Re-registration:

REG

Products Informtion

---

Name:

BIOCAN DHPPi+LR

Registration Date:

2019-11-14 00:00:00

Generic Name:

Strength:

1ML/DOSE

Classification:

HIGH RISK

Active Ingredient:

VIRUS RABIEI INACTIVATED MIN. 2 IU,LEPTOSPIRA ICTEROHAEMORRHAGIAE INACT. MIN. 1 X 107,0, LEPTOSPIRA CANICOLA INACT. MIN. 1 X 107,0, LEPTOSPIRA GRIPPOTYPHOSA INACT. MIN. 1 X 107,0, ALGELDRATI SUSPENSIO, NUTRIMENTUM AD CULTIVATIONEM

Dosage Form Indication:

POWDER FOR RECONSTTUTION FOR INJECTION_FOR THE ACTIVE IMMUNIZATION OF DOGS AGAINST DISTEMPER, INFECTIOUS HEPATITIS, INFECTIOUS LARYNGOTRACHEITIS, PARVOVIROSIS, PARAINFLUENZA, RABIES AND THE MOST FREQUENTLY OCCURRED LEPTOSPIRA SEROVARS (LEPTOSPIRA ICTEROHAEMORRHAGIAE, LEPTOSPIRA CANICOLA, LEPTOSPIRA GRIPPOTYPHOSA) IN DOGS AT THE AGE OF 12 WEEKS AND ABOVE.

Representative Company:

Multivet (Gh) Limited

Manufacturer:

BIOVETA A .S KOMENSKEHO 212/12. 68323 IVANOVICE NA HE CZECH REPUBLIC

Applicant:

BIOVETA A .S KOMENSKEHO 212/12. 68323 IVANOVICE NA HE CZECH REPUBLIC

Expiry_date:

2022-01-12 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

BIOCAN DHPPi+L

Registration Date:

2019-11-14 00:00:00

Generic Name:

Strength:

1ML/DOSE

Classification:

HIGH RISK

Active Ingredient:

LEPTOSPIRA ICTEROHAEMORRHAGIAE INACT. LEPTOSPIRA CANICOLA INACT. LEPTOSPIRA GRIPPOTYPHOSA INACT. 2% ALUMINIUM HYDROXIDE GEL, SODIUM MERTHIOLATE, CULTURING MEDIUM

Dosage Form Indication:

POWDER FOR RECONSTTUTION FOR INJECTION_FOR THE ACTIVE IMMUNIZATION OF DOGS AGAINST DISTEMPER, INFECTIOUS HEPATITIS, INFECTIOUS LARYNGOTRACHEITIS, PARVOVIROSIS, PARAINFLUENZA AND THE MOST FREQUENTLY OCCURRED LEPTOSPIRA SEROVARS IN DOGS AT THE AGE OF 8 WEEKS AND ABOVE.

Representative Company:

Multivet (Gh) Limited

Manufacturer:

BIOVETA A .S KOMENSKEHO 212/12. 68323 IVANOVICE NA HE CZECH REPUBLIC

Applicant:

BIOVETA A .S KOMENSKEHO 212/12. 68323 IVANOVICE NA HE CZECH REPUBLIC

Expiry_date:

2022-01-12 00:00:00

Registration / Re-registration:

RE-REG

Products Informtion

---

Name:

MABTHERA SC

Registration Date:

2018-11-04 00:00:00

Generic Name:

HYALURODINASE

Strength:

1600 MG

Classification:

HIGH RISK

Active Ingredient:

RITUXIMAB

Dosage Form Indication:

INJECTABLE SOLUTION_FOR NON-HODGKIN'S LYMPHOMA (NHL), TREATMENT OF UNTREATED PATIENTS WITH STAGE III-IV FOLLICULAR LYMPHOMA IN COMBINATION WITH CHEMOTHERAPY

Representative Company:

F. HOFFMAN LA-ROCHE GHANA LTD

Manufacturer:

F. HOFFMANN-LA ROCHE LTD.(Switzerland)

Applicant:

F. HOFFMAN LA-ROCHE GHANA LTD

Expiry_date:

2022-01-01 00:00:00

Registration / Re-registration:

REG